These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 24311110)
1. Antioxidants and vision health: facts and fiction. Grover AK; Samson SE Mol Cell Biochem; 2014 Mar; 388(1-2):173-83. PubMed ID: 24311110 [TBL] [Abstract][Full Text] [Related]
2. N-Acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient population. Babizhayev MA; Burke L; Micans P; Richer SP Clin Interv Aging; 2009; 4():31-50. PubMed ID: 19503764 [TBL] [Abstract][Full Text] [Related]
4. Multivitamin-multimineral supplements and eye disease: age-related macular degeneration and cataract. Seddon JM Am J Clin Nutr; 2007 Jan; 85(1):304S-307S. PubMed ID: 17209215 [TBL] [Abstract][Full Text] [Related]
5. An eye on nutrition: The role of vitamins, essential fatty acids, and antioxidants in age-related macular degeneration, dry eye syndrome, and cataract. McCusker MM; Durrani K; Payette MJ; Suchecki J Clin Dermatol; 2016; 34(2):276-85. PubMed ID: 26903189 [TBL] [Abstract][Full Text] [Related]
6. Evidence for the use of nutritional supplements and herbal medicines in common eye diseases. West AL; Oren GA; Moroi SE Am J Ophthalmol; 2006 Jan; 141(1):157-66. PubMed ID: 16386992 [TBL] [Abstract][Full Text] [Related]
7. Controversies in the Use of Nutritional Supplements in Ophthalmology. Lawrenson JG; Grzybowski A Curr Pharm Des; 2015; 21(32):4667-72. PubMed ID: 26350529 [TBL] [Abstract][Full Text] [Related]
8. State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases. Babizhayev MA; Kasus-Jacobi A Curr Clin Pharmacol; 2009 Jan; 4(1):4-37. PubMed ID: 19149498 [TBL] [Abstract][Full Text] [Related]
9. Lutein Supplementation for Eye Diseases. Li LH; Lee JC; Leung HH; Lam WC; Fu Z; Lo ACY Nutrients; 2020 Jun; 12(6):. PubMed ID: 32526861 [TBL] [Abstract][Full Text] [Related]
10. The potential preventive effects of vitamins for cataract and age-related macular degeneration. Jacques PF Int J Vitam Nutr Res; 1999 May; 69(3):198-205. PubMed ID: 10389028 [TBL] [Abstract][Full Text] [Related]
11. N-acetylcarnosine lubricant eyedrops possess all-in-one universal antioxidant protective effects of L-carnosine in aqueous and lipid membrane environments, aldehyde scavenging, and transglycation activities inherent to cataracts: a clinical study of the new vision-saving drug N-acetylcarnosine eyedrop therapy in a database population of over 50,500 patients. Babizhayev MA; Micans P; Guiotto A; Kasus-Jacobi A Am J Ther; 2009; 16(6):517-33. PubMed ID: 19487926 [TBL] [Abstract][Full Text] [Related]
12. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Evans JR; Lawrenson JG Cochrane Database Syst Rev; 2012 Nov; 11():CD000254. PubMed ID: 23152201 [TBL] [Abstract][Full Text] [Related]
13. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Age-Related Eye Disease Study Research Group Arch Ophthalmol; 2001 Oct; 119(10):1417-36. PubMed ID: 11594942 [TBL] [Abstract][Full Text] [Related]
14. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Richer S; Stiles W; Statkute L; Pulido J; Frankowski J; Rudy D; Pei K; Tsipursky M; Nyland J Optometry; 2004 Apr; 75(4):216-30. PubMed ID: 15117055 [TBL] [Abstract][Full Text] [Related]
15. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Evans JR; Lawrenson JG Cochrane Database Syst Rev; 2012 Jun; (6):CD000253. PubMed ID: 22696317 [TBL] [Abstract][Full Text] [Related]
16. The role of lutein in eye-related disease. Koushan K; Rusovici R; Li W; Ferguson LR; Chalam KV Nutrients; 2013 May; 5(5):1823-39. PubMed ID: 23698168 [TBL] [Abstract][Full Text] [Related]
17. Review of Evidence for the Usage of Antioxidants for Eye Aging. Choo PP; Woi PJ; Bastion MC; Omar R; Mustapha M; Md Din N Biomed Res Int; 2022; 2022():5810373. PubMed ID: 36225983 [TBL] [Abstract][Full Text] [Related]
19. A focus on resveratrol and ocular problems, especially cataract: From chemistry to medical uses and clinical relevance. Goutham G; Manikandan R; Beulaja M; Thiagarajan R; Arulvasu C; Arumugam M; Setzer WN; Daglia M; Nabavi SF; Nabavi SM Biomed Pharmacother; 2017 Feb; 86():232-241. PubMed ID: 28006748 [TBL] [Abstract][Full Text] [Related]
20. New concept in nutrition for the maintenance of the aging eye redox regulation and therapeutic treatment of cataract disease; synergism of natural antioxidant imidazole-containing amino acid-based compounds, chaperone, and glutathione boosting agents: a systemic perspective on aging and longevity emerged from studies in humans. Babizhayev MA Am J Ther; 2010; 17(4):373-89. PubMed ID: 20463577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]